000 01346 a2200385 4500
005 20250516210543.0
264 0 _c20140922
008 201409s 0 0 eng d
022 _a1532-6535
024 7 _a10.1038/clpt.2014.90
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCarleton, B C
245 0 0 _aResponse to "evaluation of pharmacogenetic markers to predict the risk of Cisplatin-induced ototoxicity".
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cAug 2014
300 _a158 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aCatechol O-Methyltransferase
_xgenetics
650 0 4 _aCisplatin
_xtoxicity
650 0 4 _aFemale
650 0 4 _aHearing Loss
_xchemically induced
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethyltransferases
_xgenetics
650 0 4 _aMultidrug Resistance-Associated Proteins
_xgenetics
700 1 _aRoss, C J
700 1 _aBhavsar, A P
700 1 _aLee, J W
700 1 _aVisscher, H
700 1 _aRassekh, S R
700 1 _aHayden, M R
773 0 _tClinical pharmacology and therapeutics
_gvol. 96
_gno. 2
_gp. 158
856 4 0 _uhttps://doi.org/10.1038/clpt.2014.90
_zAvailable from publisher's website
999 _c23759645
_d23759645